Antiviral efficacy of RAY1216 monotherapy and combination therapy with ritonavir in patients with COVID-19: a phase 2, single centre, randomised, double-blind, placebo-controlled trial.

Bei Wang,Hai-Jun Li, Mi-Mi Cai,Zhao-Xin Lin, Xia-Fei Ou, Shu-Hua Wu, Rui-Huan Cai, Ying-Na Wei, Fei Yang, Ya-Min Zhu,Zi-Feng Yang,Nan-Shan Zhong,Ling Lin

EClinicalMedicine（2023）

引用 0|浏览16

暂无评分

摘要

This study was sponsored by the Key Research and Development Program of China (2022YFC0868700).

查看译文

关键词

SARS-CoV-2,COVID-19,3-Chymotrypsin-like cysteine protease,RAY1216,Viral shedding time,Efficacy and safety

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要